Dalian BIO-CHEM Company Limited (603360.SS)
CNY 21.87
(0.41%)
CNY 21.87
(0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.06 Billion | 1.25 Billion | 1 Billion | 749.54 Million | 871.89 Million | 528.17 Million |
| Cost of Revenue | 511.23 Million | 588.57 Million | 536.46 Million | 335.8 Million | 340.75 Million | 273.24 Million |
| Gross Profit | 554.42 Million | 668.08 Million | 469.79 Million | 413.73 Million | 531.13 Million | 254.92 Million |
| Operating Expenses | 168.5 Million | 203.66 Million | 153.34 Million | 142.7 Million | 165.14 Million | 90.72 Million |
| Selling, General and Administrative Expenses | 119.09 Million | 62.81 Million | 72.58 Million | 60.12 Million | 102.96 Million | 37.22 Million |
| Research and Development Expenses | 38.97 Million | 47.13 Million | 40.03 Million | 28.56 Million | 28.13 Million | 19.14 Million |
| Other Expenses | 2.65 Million | 93.72 Million | 40.71 Million | 54.01 Million | 34.04 Million | -497.45 Thousand |
| Cost and Expenses | 688.21 Million | 792.24 Million | 689.8 Million | 478.51 Million | 505.9 Million | 363.96 Million |
| Operating Income | 385.92 Million | 461.62 Million | 302.72 Million | 260.71 Million | 367.54 Million | 172.11 Million |
| Interest Expense | 3.89 Million | 3.71 Million | 11.76 Million | 7.68 Million | 2.36 Million | 1.07 Million |
| Income Tax Expense | 57.4 Million | 58.86 Million | 41.54 Million | 38.51 Million | 60.62 Million | 26.55 Million |
| Earnings before Tax | 385.77 Million | 461.43 Million | 292.03 Million | 260.26 Million | 367.42 Million | 171.62 Million |
| Net Income | 328.37 Million | 402.56 Million | 250.49 Million | 221.75 Million | 306.8 Million | 145.18 Million |
| Earnings Per Share Basic | 0.66 | 1.20 | 0.71 | 0.61 | 0.84 | 0.40 |
| Earnings Per Share Diluted | 0.66 | 1.20 | 0.71 | 0.61 | 0.84 | 0.40 |
| Weighted Average Shares Outstanding | 494.32 Million | 334.78 Million | 350.68 Million | 365.24 Million | 365.88 Million | 364.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 494.32 Million | 334.78 Million | 354.23 Million | 365.24 Million | 365.88 Million | 364.83 Million |
| Gross Margin | 0.52 | 0.53 | 0.47 | 0.55 | 0.61 | 0.48 |
| EBIT Margin | 0.43 | 0.44 | 0.35 | 0.43 | 0.47 | 0.37 |
| Profit Margin | 0.31 | 0.32 | 0.25 | 0.30 | 0.35 | 0.27 |
| EBITDA | 453.71 Million | 537.38 Million | 356.24 Million | 311.37 Million | 404.76 Million | 197.07 Million |
| Earnings Before Tax Margin | 0.36 | 0.37 | 0.30 | 0.35 | 0.42 | 0.33 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 309.72 Million | 244.66 Million | 338.25 Million | 1.06 Billion | 214.77 Million | 277.84 Million |
| Cost of Revenue | 165.14 Million | 134.02 Million | 182.95 Million | 511.23 Million | 114.79 Million | 128.25 Million |
| Gross Profit | 144.58 Million | 110.64 Million | 155.29 Million | 554.42 Million | 99.98 Million | 149.59 Million |
| Operating Expenses | 46.89 Million | 45.88 Million | 42.92 Million | 176.98 Million | 41.08 Million | 45.41 Million |
| Selling, General and Administrative Expenses | 31.86 Million | 11.75 Million | 31.17 Million | - | -33.51 Million | 58.5 Million |
| Research and Development Expenses | 15.03 Million | 11.01 Million | 10.34 Million | - | 9.56 Million | 11.35 Million |
| Other Expenses | - | -64.7 Thousand | 17.56 Thousand | -143.77 Thousand | -164.56 Thousand | 22.31 Thousand |
| Cost and Expenses | 212.04 Million | 179.9 Million | 225.87 Million | 688.21 Million | 155.88 Million | 173.67 Million |
| Operating Income | 97.68 Million | 74.38 Million | 112.46 Million | 385.92 Million | 58.57 Million | 107.35 Million |
| Interest Expense | 658.57 Thousand | 2.03 Million | 1.96 Million | 3.92 Million | 173.56 Thousand | 948.2 Thousand |
| Income Tax Expense | 10.26 Million | 8.08 Million | 14.16 Million | 57.4 Million | 12.97 Million | 14.3 Million |
| Earnings before Tax | 99.93 Million | 74.32 Million | 112.47 Million | 385.77 Million | 58.41 Million | 107.38 Million |
| Net Income | 89.67 Million | 66.23 Million | 98.31 Million | 328.37 Million | 45.43 Million | 93.07 Million |
| Earnings Per Share Basic | 0.19 | 0.14 | 0.27 | - | 0.40 | 0.26 |
| Earnings Per Share Diluted | 0.19 | 0.14 | 0.27 | - | 0.40 | 0.26 |
| Weighted Average Shares Outstanding | 484.6 Million | 484.6 Million | 364.12 Million | 353.09 Million | 347.96 Million | 357.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 484.6 Million | 484.6 Million | 364.12 Million | 353.09 Million | 347.96 Million | 357.99 Million |
| Gross Margin | 0.47 | 0.45 | 0.46 | 0.52 | 0.47 | 0.54 |
| EBIT Margin | 0.32 | 0.31 | 0.35 | - | 0.33 | 0.38 |
| Profit Margin | 0.29 | 0.27 | 0.29 | 0.31 | 0.21 | 0.33 |
| EBITDA | 100.58 Million | 75.43 Million | 117.22 Million | - | 70.08 Million | 106.8 Million |
| Earnings Before Tax Margin | 0.32 | 0.30 | 0.33 | 0.36 | 0.27 | 0.39 |
4716
6150
ASHM
BOW
SKFRY
EPC